| Literature DB >> 35800529 |
Avineet Kaur1, Harnoor S Sandhu2, Aaron Sarwal3, Shalika Bhagat2,4, Reshma Dodwad5, Gaganpreet Singh6, Ramandeep S Gambhir7.
Abstract
Background: Periodontal disease constitutes a group of diseases involving inflammatory aspects of the host caused by several microbial agents that affect periodontal tissues and could have systemic implications. Objective: The present study was conducted to assess the correlation of COVID-19 infection and severity of periodontitis in subjects who has mild form of the disease as compared to subjects having moderate form of the disease. Materials andEntities:
Keywords: COVID-19 infection; Comorbidity; periodontitis; risk
Year: 2022 PMID: 35800529 PMCID: PMC9254790 DOI: 10.4103/jfmpc.jfmpc_1978_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Demographic characteristics of study population
| Parameters | Group I | Group II |
|
|---|---|---|---|
| Gender | |||
| Male | 38 (65.5%) | 32 (55.1%) | 0.02* |
| Female | 20 (34.4%) | 26 (44.8%) | |
| Age (in y) | |||
| 18-40 | 16 (27.5%) | 18 (31%) | 0.01* |
| 41-60 | 19 (32.7%) | 21 (36.2%) | |
| 60 and above | 23 (39.6%) | 19 (32.7%) | |
| Smoking | |||
| Yes | 12 (20.6%) | 13 (23%) | 0.01* |
| No | 46 (79.3%) | 45 (77%) | |
| Co-morbidity | |||
| None | 8 (13.7%) | 26 (46.1%) | 0.04* |
| 1 | 20 (34.4%) | 18 (30.7%) | |
| >1 | 30 (51.7%) | 14 (24%) | |
| BMI | |||
| Normal | 11 (19%) | 18 (31%) | 0.72* |
| Overweight/Obese | 47 (81%) | 40 (69%) |
*P<0.05 significant, Chi-square test, BMI: body mass index
Figure 1Periodontal disease status among subjects in both the groups
Multiple logistic regression analysis on severity of periodontal disease (Scores 2-4)
| Variable | OR (odds ratio) | 95% CI |
|
|---|---|---|---|
| Groups | |||
| Group I | 6.32 | 2.80-14.62 | 0.024* |
| Group II | 1 | Ref | |
| Age-group | |||
| 18-40 | 1 | Ref | 0.045* |
| 41-60 | 2.45 | 1.34-6.78 | |
| 60 and above | 4.45 | 2.34-8.76 | |
| Smoking | |||
| Yes | 3.32 | 1.67-6.34 | 0.014* |
| No | 1 | Ref | |
| Co-morbid condition | |||
| None | 1 | Ref | 0.028* |
| 1 | 2.45 | 1.23-5.56 | |
| >1 | 4.43 | 2.56-9.45 |
OR: odds ratio; CI: confidence interval, Ref: reference. *Statistically significant
Assessment of laboratory parameters in both groups
| Periodontal condition | Variables | Group I | Group II |
|
|---|---|---|---|---|
| Stage 0-1 | HbA1c (%) | 6.8 | 5.1 | 0.05* |
| Vit-D (ng/mL) | 24.2 | 18.2 | 0.14 | |
| D-Dimer (mg/L) | 0.52 | 0.43 | 0.32 | |
| Lymphocyte (103/µL) | 1.86 | 1.71 | 0.04* | |
| WBC (103/µL) | 5.9 | 5.1 | 0.07 | |
| CRP (mg/L) | 7.8 | 4.5 | 0.02* | |
| Stage 2-4 | HbA1c (%) | 6.9 | 5.3 | 0.04* |
| Vit-D (ng/mL) | 24.6 | 18.0 | 0.16 | |
| D-Dimer (mg/L) | 0.58 | 0.41 | 0.34 | |
| Lymphocyte (103/µL) | 1.90 | 1.52 | 0.03* | |
| WBC (103/µL) | 6.2 | 5.0 | 0.02* | |
| CRP (mg/L) | 7.9 | 4.2 | 0.01* |
*P<0.05 significant; HbA1c: glycosylated hemoglobin; Vit D: vitamin D; WBC: white blood cell; CRP: C-reactive protein